Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility of salivary cortisol collection in patients and companions attending dementia diagnostic meetings in memory clinics.

BMC research notes·2021
Same author

Growth hormone secretion, fatigue and quality of life after childhood traumatic brain injury.

European journal of endocrinology·2019
Same author

Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17.

Annals of the rheumatic diseases·2014
Same author

Systemic steroid prophylaxis for cataract surgery in patients with posterior uveitis.

Ocular immunology and inflammation·2012
Same author

Primary trabeculectomy with 5-fluorouracil for glaucoma secondary to uveitis.

Ocular immunology and inflammation·2012
Same author

Maternal mood and neuroendocrine programming: effects of time of exposure and sex.

Journal of neuroendocrinology·2012
Same journal

Role of Adjunctive Intravitreal Therapy in Intraocular Tubercular Granuloma at a Tertiary Uveitis Care Centre - A Retrospective Case Series.

Ocular immunology and inflammation·2026
Same journal

Sex Differences in Uveitis Etiology: A Systematic Review and Meta-Analysis.

Ocular immunology and inflammation·2026
Same journal

Upadacitinib in Refractory Vogt-Koyanagi-Harada Disease: A Case Report.

Ocular immunology and inflammation·2026
Same journal

Choroidal and Retinal Imaging Findings in Childhood-Onset Mevalonate Kinase Deficiency: An OCT-Based Case-Control Study.

Ocular immunology and inflammation·2026
Same journal

Efficacy of infliximab therapy in the treatment of idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome.

Ocular immunology and inflammation·2026
Same journal

Conjunctival Reactive Lymphoid Hyperplasia with Delayed Corneal Immune Infiltrates in the Setting of Systemic Epstein-Barr Virus Infection.

Ocular immunology and inflammation·2026
See all related articles

Related Experiment Video

Updated: May 20, 2026

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia
06:15

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

Visual prognosis in Behçet's disease.

H M Towler1, S Lightman

  • 1Department of Clinical Science, Institute of Ophthalmology, Moorfields Eye Hospital, London, UK.

Ocular Immunology and Inflammation
|July 25, 2012
PubMed
Summary
This summary is machine-generated.

Aggressive treatment improves vision in Behçet

More Related Videos

Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

Related Experiment Videos

Last Updated: May 20, 2026

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia
06:15

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Immunology

Background:

  • Behçet's disease historically has a poor visual prognosis, with up to 74% vision loss.
  • Previous studies focused on Mediterranean populations; ethnic variations in ocular Behçet's disease progression are suggested.
  • Long-term effects of newer immunosuppressants like cyclosporin on visual outcomes are not well-established.

Purpose of the Study:

  • To evaluate the visual prognosis of patients with Behçet's disease and ocular involvement.
  • To assess the effectiveness of aggressive, multi-agent immunosuppressive therapy on visual outcomes.

Main Methods:

  • Retrospective analysis of 28 patients with ocular Behçet's disease of mixed ethnicity.
  • Average follow-up of six years.
  • Aggressive treatment of posterior segment disease relapse using corticosteroids, cyclosporin, azathioprine, cyclophosphamide, or chlorambucil.

Main Results:

  • Currently, 60% of patients maintain visual acuity of ± 6/9 in the better eye.
  • 21% of patients have visual acuity between 6/12 and 6/60.
  • 18% of patients have visual acuity worse than 6/60.

Conclusions:

  • Aggressive immunosuppressive therapy appears to improve visual prognosis in Behçet's disease.
  • Current encouraging results suggest a shift from historical poor visual outcomes.
  • Continued aggressive management is warranted based on these relatively short-term findings.